The document describes a potential new cancer treatment called The CanPill. The CanPill is a pill that can be injected intravenously and travel through the bloodstream to deliver high doses of anticancer drugs directly to tumors, without affecting surrounding healthy tissue. It provides a solution to the challenge of effectively delivering drugs to cancer sites by targeting delivery precisely. The author seeks funding to make The CanPill a reality and improve outcomes for cancer patients.